Additional Results of POSLUMA (Flotufolastat F 18) Performance in Newly Diagnosed, High-risk Prostate Cancer Patients Presented at ASTRO
Imaging Technology
OCTOBER 5, 2023
Kuo, MD, Ph.D. , Departments of Medical Imaging, Medicine, and Biomedical Engineering. The demonstrated performance of PSMA-PET imaging fits an important unmet need, given that conventional imaging techniques are limited in the information they provide. on behalf of Gary A. Blue Earth Diagnostics received U.S.
52 
Let's personalize your content